As the compounding industry continues to grow, expectations for pharmacy compounders grow as well. Vigorous research and transparent scientific data are paramount to proving and promoting the impact of compounded medicines on patients.

Two recent compounding case studies describe treatments that helped adults with persistent drooling as well as cats with behavioral issues.

PCCA's Chief Scientific Officer Gus Bassani provides an important and exciting update regarding the work of our Research and Development department over the last 18 months.